Tanu Sharma's blog

The global Mice Model Market was valued at USD 2.5 billion in 2025 and is projected to reach USD 6.9 billion by the end of 2035, expanding at a CAGR of 10.5% during the forecast period. The market is experiencing strong growth due to increasing utilization of laboratory mouse models in biomedical research, preclinical testing, oncology studies, genetic engineering, and personalized medicine development. The growing dependence on genetically engineered mice for translational research and therapeutic validation continues to accelerate market expansion worldwide.

The global Healthcare Information Software Market has become a foundational component of modern healthcare infrastructure, driven by increasing digital transformation initiatives, rising healthcare data volumes, and the growing need for efficient patient management systems. The market was valued at approximately USD 37.6 billion in 2025 and is projected to reach nearly USD 79.6 billion by 2035, registering a compound annual growth rate (CAGR) of 8.7% during the forecast period.

The global biopolymer coatings market has emerged as a rapidly expanding segment within the sustainable materials and specialty coatings industry, driven by increasing environmental concerns, stringent regulations on synthetic plastics, and growing demand for eco-friendly packaging and industrial materials. The market was valued at approximately USD 38 billion in 2025 and is expected to reach nearly USD 118 billion by the end of 2035, expanding at a compound annual growth rate (CAGR) of 12% during the forecast period.

The global construction adhesives market represents a critical segment within the broader construction chemicals industry, driven by increasing infrastructure development, urbanization, and demand for high-performance bonding solutions across residential, commercial, and industrial construction activities. The market was valued at approximately USD 12.1 billion in 2025 and is projected to reach nearly USD 18.1 billion by 2035, registering a compound annual growth rate (CAGR) of 4.6% during the forecast period.

The global dairy testing market has become an essential component of the food safety and quality assurance industry due to increasing consumer awareness, strict food regulations, and rising international dairy trade activities. The market was valued at approximately USD 8.3 billion in 2025 and is projected to reach nearly USD 17.7 billion by 2035, expanding at a compound annual growth rate (CAGR) of 8.8% during the forecast period.

The global Graphite Electrodes Market was valued at USD 17.3 billion in 2025 and is expected to reach USD 26.3 billion by the end of 2035, growing at a CAGR of 4.8% during the forecast period. The market continues to expand steadily due to the rising utilization of electric arc furnace steelmaking, increasing demand for high-quality steel production, and the growing role of graphite electrodes in energy-intensive industrial applications.

The global preclinical cro market was valued at USD 7.2 billion in 2025 and is expected to grow significantly to USD 14.5 billion by 2035, expanding at a CAGR of 8.1% during the forecast period. The market is experiencing strong momentum due to increasing pharmaceutical research activities, rising outsourcing trends among biopharmaceutical companies, and growing demand for efficient drug discovery and development services.

The global customer analytics market was valued at USD 24.4 billion in 2025 and is projected to reach USD 104.9 billion by the end of 2035, growing at a CAGR of 15.7% during the forecast period. The market is witnessing rapid expansion due to increasing digital transformation initiatives, rising adoption of artificial intelligence-driven analytics platforms, and growing demand for personalized customer engagement strategies across industries.

The global medical device outsourcing market was valued at USD 157.9 billion in 2025 and is projected to reach USD 493.5 billion by the end of 2035, growing steadily at a CAGR of 13.5% during the forecast period. The market is experiencing substantial expansion due to increasing demand for specialized manufacturing capabilities, rising regulatory complexity, and growing adoption of advanced medical technologies across healthcare systems worldwide.

The global Acute Migraine Drugs Market was valued at USD 7.3 billion in 2025 and is projected to reach USD 16.3 billion by the end of 2035, growing at a CAGR of 9.4% during the forecast period. The market is experiencing significant expansion due to the increasing prevalence of migraine disorders, rising awareness regarding neurological health, and growing demand for rapid and effective pain management therapies.